Around the Web — 4.18.23
The emerging SARS-CoV-2 subvariant XBB.1.16 may carry the previously rare symptom of conjunctivitis, according to a pediatrician in India and a news report in the
Michael Posey
April 18, 2023
The emerging SARS-CoV-2 subvariant XBB.1.16 may carry the previously rare symptom of conjunctivitis, according to a pediatrician in India and a news report in the
Opioids are an increasingly common cause of fatal poisoning among children ages 5 years or younger, followed by nonprescription pain, cold, and allergy products, according
FDA yesterday approved Emergent BioSolutions’ Narcan (naloxone hydrochloride) 4 mg nasal spray for OTC use. The action “paves the way for the life-saving medication to
A population-based cohort study from Ontario suggests no adverse infant outcomes from maternal treatment with opioids within 30 days of hospital discharge. “Although we endorse
Four proven clinical interventions “should constitute a set of ‘universal precautions’ that clinicians and health systems could implement to reduce opioid overdose deaths among at-risk
The annual rate of hospitalizations and proportion per year of acute liver failure (ALF) cases involving acetaminophen (paracetamol) and opioids fell in the years after
“The consequences of meeting the national goal of no more than 81,000 fatal drug overdoses per year by 2025 are highly consequential,” write staff members
Buprenorphine-based treatment for opioid use disorder during the COVID-19 pandemic was not associated with an increased proportion of overdose deaths involving buprenorphine, according to results
Use of buprenorphine during pregnancy in people with opioid use disorder is safer for the baby than using methadone, a cohort study shows, but adverse
The FDA and the National Institute of Standards and Technology are collaborating on a project to develop and harmonize methods to standardize the description of the temperature